David Killock
125 Coldharbour Lane
London, ENG SE59NU, United Kingdom
London, ENG SE59NU, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 298 publications
HCT-ASCT confirmed as standard-of-care consolidation therapy for PCNSL.
Journal: Nature reviews. Clinical oncology
Published: August 07, 2026
Potential new standard of care for resectable gastro-oesophageal adenocarcinoma in Asia.
Journal: Nature reviews. Clinical oncology
Published: June 12, 2026
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancer.
Journal: Nature reviews. Clinical oncology
Published: May 14, 2026
Lisocabtagene maraleucel has high efficacy in R/R MZL.
Journal: Nature reviews. Clinical oncology
Published: March 03, 2026
CDK4/6 inhibition provides additional efficacy in HER2+, HR+ breast cancer.
Journal: Nature reviews. Clinical oncology
Published: February 17, 2026
MajesTEC results with teclistamab in relapsed and/or refractory multiple myeloma.
Journal: Nature reviews. Clinical oncology
Published: January 02, 2026
T-DXd shows promise in neoadjuvant therapy for HER2+ breast cancer.
Journal: Nature reviews. Clinical oncology
Published: November 10, 2025
Frontline sacituzumab govitecan prolongs PFS in TNBC.
Journal: Nature reviews. Clinical oncology
Published: October 29, 2025
HER2-directed therapy improves urothelial cancer outcomes.
Journal: Nature reviews. Clinical oncology
Published: October 28, 2025
Sacituzumab tirumotecan improves OS in EGFR TKI-resistant NSCLC.
Journal: Nature reviews. Clinical oncology
Published: October 28, 2025
ALASCCA: an aspirin a day keeps colorectal cancer away.
Journal: Nature reviews. Clinical oncology
Published: September 27, 2025
Last Updated: 09/26/2026